参考文献
1: Raina K, Lu J, Qian Y, Altieri M, Gordon D, Rossi AM, Wang J, Chen X, Dong H,
Siu K, Winkler JD, Crew AP, Crews CM, Coleman KG. PROTAC-induced BET protein
degradation as a therapy for castration-resistant prostate cancer. Proc Natl Acad
Sci U S A. 2016 Jun 28;113(26):7124-9. doi: 10.1073/pnas.1521738113. Epub 2016
Jun 6. PubMed PMID: 27274052; PubMed Central PMCID: PMC4932933.
2: Saenz DT, Fiskus W, Qian Y, Manshouri T, Rajapakshe K, Raina K, Coleman KG,
Crew AP, Shen A, Mill CP, Sun B, Qiu P, Kadia TM, Pemmaraju N, DiNardo C, Kim MS,
Nowak AJ, Coarfa C, Crews CM, Verstovsek S, Bhalla KN. Novel BET protein
proteolysis-targeting chimera exerts superior lethal activity than bromodomain
inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML
cells. Leukemia. 2017 Jan 31. doi: 10.1038/leu.2016.393. [Epub ahead of print]
PubMed PMID: 28042144.
